Amazon.com: Neuroanatomy Through Clinical Cases, Second Edition, Text with Interactive eBook (Blumenfeld, Neuroanatomy Through Clinical Case...
Essentials of Medical Biochemistry - With Clinical Cases
Clinical Cases in Dietetics - F. Pender (Blackwell, 2008)
Life in the Fast Lane • LITFL • Emergency medicine education and critical care education blog
The disease can present with symptoms often associated with other illnesses; following the trail of such signs early on could help with early diagnosis.
Read more about BioSig's first-in-human trial evaluating the PURE EP system, an advanced tool for recording high-quality cardiac signals during electrophysiology studies
Clinical Cases in Restorative and Reconstructive Dentistry - G. Tarantola (Wiley-Blackwell, 2010)
100 Cases in Clinical Pathology 1st Ed Your password to the book-archive is in the description under the video - https://youtu.be/trjk6cT9G6g
Online shopping from a great selection at Books Store.
Long Cases in Clinical Medicine Concerned With Long Cases, Their Presentation, Related Questions, Answers and Discussions
• Artificial intelligence, machine learning will create a greater platform for clinical development in the future.• The AI tools will be more beneficial than...
Download Vector germ, bacteria and virus icons Stock Vector and explore similar vectors at Adobe Stock
Pulmonary Tuberculosis with bulla
Postural tachycardia syndrome (POTS) is a syndrome of excessive tachycardia with orthostatic challenge, and relief of such symptoms with recumbence. There
Background Pregnancies complicated by a number of rheumatic diseases are known to be at high risk for the occurrence of adverse pregnancy outcomes (APOs). There have been several reports on the risk of APOs in systemic lupus erythematosus and rheumatoid arthritis, but few reports on polymyositis (PM)/dermatomyositis (DM) pregnancies. There are also insufficient reports on changes in the activity of PM/DM during pregnancy. Based on the findings reported in other rheumatic diseases, it is suggested that increased activity during pregnancy is associated with APOs in PM/DM (1-3). However, the risk factors for pregnancy outcome in pregnancies complicated by PM/DM, including the presence or absence of worsening of disease activity, have not been clarified. Objectives The purpose of this study was to analyze a case series of PM/DM complicated pregnancies in a single center to determine the changes in disease activity during pregnancy and pregnancy outcomes. Methods PM/DM patients who were managed from pregnancy to delivery at Kagawa University Hospital from March 2006 to May 2021 were included in this study. Clinical indices including duration of illness, disease activity, and treatment were extracted from medical records and retrospectively analyzed for association with pregnancy outcome. Results Eight PM/DM pregnancies were included in the analysis. The mean age at delivery was 28.3±3.8 years and the mean duration of disease was 6.3±3.2 years. Treatment at the time of pregnancy included glucocorticoids (GC) in 7 cases and immunosuppressive drugs in 5 cases. Creatinine phosphokinase (CK) levels were normal in all patients at the time of pregnancy, but increased during pregnancy in 4 (50%) patients. These 4 patients with elevated CK required treatment with increasing doses of GC, and the mean GC dose during pregnancy was 10.9 ± 6.0 mg/day. [Table 1][1] shows the pregnancy outcomes of the 8 patients. There was one spontaneous abortion and seven live births. Among the live births, 2 were preterm and 4 were low birth weight. The mean gestational age at delivery was 35.3±5.2 weeks and the mean birth weight was 2297.7±1041.4g. View this table: Table 1. Pregnancy outcomes of eight cases The birth outcomes of the 2 patients who received continuous immunosuppressive therapy were full-term and normal weight infants. APOs, such as preterm delivery and low birth weight, occurred in cases with increased CK levels and increased GC doses. Conclusion In pregnancies of PM/DM patients, pregnancy outcome was less than favorable. An association between disease activity and the development of APOs during pregnancy in PM/DM was suggested. An association was also suggested between GC dose and the risk of developing APOs. As in other rheumatic disease pregnancies, continued use of pregnancy-appropriate immunosuppressive drugs and control of disease activity with lower glucocorticoid doses in PM/DM pregnancies may be important to achieve good pregnancy outcomes. References [1]Nagy-Vincze M, Vencovsky J, Lundberg IE, Danko K (2014) Pregnancy outcome in idiopathic inflammatory myopathy patients in a multicenter study. J Rheumatol 41:2492-2494. [2]Zhong Z, Lin F, Yang J, Zhang F, Zeng X, You X (2017) Pregnancy in polymyositis or dermatomyositis: retrospective results from tertiary centre in China. Rheumatology (Oxford) 56:1272-1275. [3]Kolstad KD, Fiorentino D, Li S, Chakravarty EF, Chung L (2018) Pregnancy outcomes in adult patients with dermatomyositis and polymyositis. Semin Arthritis Rheum 47:865-869. Disclosure of Interests None declared [1]: #T1
.
Article: Pathologic morphology and clinical significance of the anomalous origin of the left circumflex coronary artery from the right coronary art
Present data about Respiratory Clinical Cases with this simple medical presentation. Download it as Google Slides theme or PowerPoint template!
Try a new approach when giving medical presentations by using this Google Slides & PowerPoint template, perfect for explaining clinical cases
Make the most of a vintage-looking presentation for clinical cases and add some visual quality to your slideshow. Contains editable resources!
